Status: Recruiting
Mts105 for Advanced Hepatocellular Carcinoma
This is the first-in-human trial of MTS105 (mRNA-LNP). The goal of this clinical trial is to evaluate the safety, tolerability of intravenous injection of MTS105 in advanced hepatocellular carcinoma.
Participants needed: 14
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Shen LinUpdated: Dec 24, 2024Locations: 1
Eligibility criteria
Histologically or cytologically confirmed diagnosis of hepatocellular carcinoma... [+13]
Any known active intracranial metastases, or brain metastases that have been tre... [+23]